140 related articles for article (PubMed ID: 15175981)
1. [Guidelines for the treatment of spasticity in adults using Botulinum toxin].
Aguilar-Barberá M; Bori-Fortuny I; García-Aymerich V; García-Ruiz Espiga PJ; Garreta-Figuera R; Herrera-Galante A; Lanzas-Melendo G; de Miguel-León I; Miquel-Rodríguez F; Pascual-Pascual SI; Póo P; Vivancos-Matellano F
Rev Neurol; 2004 May 16-31; 38(10):971-8. PubMed ID: 15175981
[TBL] [Abstract][Full Text] [Related]
2. [Guidelines for the treatment of child spasticity using botulinum toxin].
Pascual-Pascual SI; Herrera-Galante A; Póo P; García-Aymerich V; Aguilar-Barberà M; Bori-Fortuny I; García-Ruiz PJ; Garreta-Figuera R; Lanzas-Melendo G; de Miguel-León I; Miquel-Rodríguez F; Vivancos-Matellano F;
Rev Neurol; 2007 Mar 1-15; 44(5):303-9. PubMed ID: 17342682
[TBL] [Abstract][Full Text] [Related]
3. [Botulinum toxin in spasticity treatment].
Sławek J
Neurol Neurochir Pol; 1998; 32 Suppl 1():71-84. PubMed ID: 9608556
[TBL] [Abstract][Full Text] [Related]
4. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
[TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin type A in the management of spasticity in adults: recommendations of an interdisciplinary group of experts].
Sławek J; Bogucki A; Banach M; Członkowska A; Friedman A; Krawczyk M; Kwolek A; Opara J; Ochudło S; Zaborski J
Neurol Neurochir Pol; 2004; 38(6):443-5. PubMed ID: 15654667
[No Abstract] [Full Text] [Related]
6. Walking assessment with instrumented insoles in patients with lower limb spasticity after botulinum toxin infiltration.
Béseler MR; Grao CM; Gil A; Martínez Lozano MD
Neurologia; 2012; 27(9):519-30. PubMed ID: 22088852
[TBL] [Abstract][Full Text] [Related]
7. Managing spasticity with drugs.
Simon O; Yelnik AP
Eur J Phys Rehabil Med; 2010 Sep; 46(3):401-10. PubMed ID: 20927006
[TBL] [Abstract][Full Text] [Related]
8. [Early pain reduction in the treatment of spasticity after a single injection of botulinum A toxin].
Chalkiadaki A; Rohr UP; Hefter H
Dtsch Med Wochenschr; 2001 Nov; 126(48):1361-4. PubMed ID: 11727162
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A in children. New indication for limb spasticity.
Prescrire Int; 2011 Mar; 20(114):68. PubMed ID: 21648226
[No Abstract] [Full Text] [Related]
10. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
11. The use of botulinum toxin type A in the management of adult-onset focal spasticity: a survey of Australian allied health professionals.
Williams G; Olver J; de Graaff S; Singer BJ
Aust Occup Ther J; 2012 Aug; 59(4):257-64. PubMed ID: 22934898
[TBL] [Abstract][Full Text] [Related]
12. Estimation of botulinum toxin type A efficacy on spasticity and functional outcome in children with spastic cerebral palsy.
Colovic H; Dimitrijevic L; Stankovic I; Nikolic D; Radovic-Janosevic D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):41-7. PubMed ID: 22580859
[TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin Type A. Indications and results].
Póo P; López-Casas JA; Galván-Manso M; Aquino-Fariña L; Terricabras-Carol L; Campistol J
Rev Neurol; 2003 Jul 1-15; 37(1):74-80. PubMed ID: 12861515
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin for the treatment of spasticity in children: attainment of treatment goals.
Weigl DM; Arbel N; Katz K; Becker T; Bar-On E
J Pediatr Orthop B; 2007 Jul; 16(4):293-6. PubMed ID: 17527109
[TBL] [Abstract][Full Text] [Related]
15. Letter to the editor: Re: Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.
Dubinsky RM
Clin Rehabil; 2010 Aug; 24(8):766. PubMed ID: 20702516
[No Abstract] [Full Text] [Related]
16. [Indications and management of botulinum toxin].
Singer C
Rev Neurol; 1999 Jul 16-31; 29(2):157-62. PubMed ID: 10528331
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin injection of the subscapularis muscle.
Unlu E; Sen T; Umay E; Bal B; Elhan A; Cakci A
J Clin Neurosci; 2010 Oct; 17(10):1265-6. PubMed ID: 20591673
[TBL] [Abstract][Full Text] [Related]
19. International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction.
Esquenazi A; Novak I; Sheean G; Singer BJ; Ward AB
Eur J Neurol; 2010 Aug; 17 Suppl 2():1-8. PubMed ID: 20633176
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of botulinum toxin in neurological indications.
Ward AB; Molenaers G; Colosimo C; Berardelli A
Eur J Neurol; 2006 Dec; 13 Suppl 4():20-6. PubMed ID: 17112346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
